TABLE 1.
Baseline clinical features of the patient (n = 101) and control (n = 48) cohorts
| Clinical feature | Patient Cohort n (%) | Control Cohort n (%) | P value |
|---|---|---|---|
| Age (median, IQR) | 66 (60–71) | 64 (59‐71) | .480 |
| Sex | |||
| Male | 58 (57) | 14 (29) | .001 |
| Female | 43 (43) | 34 (71) | |
| Any comorbidity | 51 (50) | 43 (90) | <.001 |
| Hypertension | 36 (36) | 32 (67) | <.001 |
| Diabetes mellitus | 18 (18) | 21 (44) | .001 |
| Coronary heart disease | 10 (10) | 8 (17) | .236 |
| Hypothyroidism | 8 (8) | 5 (10.4) | .757 |
| Primary tumor | |||
| Lung | 24 (24) | ||
| Colorectal | 21 (21) | ||
| Breast | 9 (9) | ||
| Hepatobiliary | 9 (9) | ||
| Gynecological | 8 (8) | ||
| Genitourinary | 7 (7) | ||
| Gastric | 7 (7) | ||
| Other | 16 (15) | ||
| Disease stage | |||
| Localized | 23 (23) | ||
| Advanced | 78 (77) | ||
| Treatment type | |||
| Chemotherapy | 79 (79) | ||
| Immunotherapy | 21 (20) | ||
| Immunotherapy + chemotherapy | 1 (1) | ||
Abbreviation: IQR, interquartile range.